Advertisement
Singapore markets close in 2 hours 6 minutes
  • Straits Times Index

    3,174.43
    -13.23 (-0.42%)
     
  • Nikkei

    37,068.35
    -1,011.35 (-2.66%)
     
  • Hang Seng

    16,225.68
    -160.19 (-0.98%)
     
  • FTSE 100

    7,877.05
    +29.06 (+0.37%)
     
  • Bitcoin USD

    64,084.76
    +3,096.86 (+5.08%)
     
  • CMC Crypto 200

    1,291.01
    -21.61 (-1.65%)
     
  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     
  • Dow

    37,775.38
    +22.07 (+0.06%)
     
  • Nasdaq

    15,601.50
    -81.87 (-0.52%)
     
  • Gold

    2,397.00
    -1.00 (-0.04%)
     
  • Crude Oil

    83.81
    +1.08 (+1.31%)
     
  • 10-Yr Bond

    4.6470
    0.0000 (0.00%)
     
  • FTSE Bursa Malaysia

    1,550.17
    +5.41 (+0.35%)
     
  • Jakarta Composite Index

    7,063.10
    -103.72 (-1.45%)
     
  • PSE Index

    6,420.75
    -102.44 (-1.57%)
     

Teva to Lose 20–25 Sites, Cut 14,000 Workers in Next 2 Years

Teva to Lose 20–25 Sites, Cut 14,000 Workers in Next 2 Years

Can Teva Pharmaceutical's Restructuring Plan Help It Recuperate? As part of its recent restructuring plan, Teva Pharmaceutical Industries (TEVA) announced a $3 billion restructuring plan in December 2017. As part of its cost-saving initiative, the company plans to shut down some of its manufacturing facilities and cut its employee base.